 | • レポートコード：MRC2102QY10199 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、142ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界のOTC薬市場について種類別（クラスA、クラスB）、用途別（病院、診療所、家庭）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・OTC薬市場の概要 ・世界の主要地域別OTC薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のOTC薬市場規模2015-2026：種類別（クラスA、クラスB） ・世界のOTC薬市場規模2015-2026：用途別（病院、診療所、家庭） ・OTC薬の米国市場規模2015-2020 ・OTC薬のヨーロッパ市場規模2015-2020 ・OTC薬の中国市場規模2015-2020 ・OTC薬の日本市場規模2015-2020 ・OTC薬の東南アジア市場規模2015-2020 ・OTC薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・OTC薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・OTC薬の市場動向・機会・課題 ・調査の結論 |
Non-prescription drugs refer to drugs that can be purchased for the convenience of the public without a prescription from a physician or other medical professional. The general public can use the drugs on their own discretion according to the drug labels and instructions.
Market Analysis and Insights: Global OTC Drug Market
The global OTC Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global OTC Drug Scope and Market Size
The global OTC Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global OTC Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the OTC Drug market is segmented into
Class A
Class B
Segment by Application, the OTC Drug market is segmented into
Hospital
Clinic
Household
The OTC Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the OTC Drug market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and OTC Drug Market Share Analysis
OTC Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in OTC Drug business, the date to enter into the OTC Drug market, OTC Drug product introduction, recent developments, etc.
The major vendors covered:
Bayer HealthCare
GlaxoSmithKline (GSK)
Johnson&Johnson
Pfizer
Sanofi
AstraZeneca
BioGaia
Bristol Myers Squibb
Bukwang Pharmaceutica
Chr. Hansen
Cipla
CoLucid
Daiichi Sankyo
Friggs
DSM
Eisai
Eli Lilly
Herbalife
Euradite
1 OTC Drug Market Overview
1.1 OTC Drug Product Scope
1.2 OTC Drug Segment by Type
1.2.1 Global OTC Drug Sales by Type (2020-2026)
1.2.2 Class A
1.2.3 Class B
1.3 OTC Drug Segment by Application
1.3.1 Global OTC Drug Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Household
1.4 OTC Drug Market Estimates and Forecasts (2015-2026)
1.4.1 Global OTC Drug Sales Growth Rate (2015-2026)
1.4.2 Global OTC Drug Revenue and Growth Rate (2015-2026)
1.4.3 Global OTC Drug Price Trends (2015-2026)
2 OTC Drug Estimate and Forecast by Region
2.1 Global OTC Drug Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global OTC Drug Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global OTC Drug Sales Market Share by Region (2015-2020)
2.2.2 Global OTC Drug Revenue Market Share by Region (2015-2020)
2.3 Global OTC Drug Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global OTC Drug Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global OTC Drug Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States OTC Drug Estimates and Projections (2015-2026)
2.4.2 Europe OTC Drug Estimates and Projections (2015-2026)
2.4.3 China OTC Drug Estimates and Projections (2015-2026)
2.4.4 Japan OTC Drug Estimates and Projections (2015-2026)
2.4.5 Southeast Asia OTC Drug Estimates and Projections (2015-2026)
2.4.6 India OTC Drug Estimates and Projections (2015-2026)
3 Global OTC Drug Competition Landscape by Players
3.1 Global Top OTC Drug Players by Sales (2015-2020)
3.2 Global Top OTC Drug Players by Revenue (2015-2020)
3.3 Global OTC Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in OTC Drug as of 2019)
3.4 Global OTC Drug Average Price by Company (2015-2020)
3.5 Manufacturers OTC Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key OTC Drug Players (Opinion Leaders)
4 Global OTC Drug Market Size by Type
4.1 Global OTC Drug Historic Market Review by Type (2015-2020)
4.1.1 Global OTC Drug Sales Market Share by Type (2015-2020)
4.1.2 Global OTC Drug Revenue Market Share by Type (2015-2020)
4.1.3 Global OTC Drug Price by Type (2015-2020)
4.2 Global OTC Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global OTC Drug Sales Forecast by Type (2021-2026)
4.2.2 Global OTC Drug Revenue Forecast by Type (2021-2026)
4.2.3 Global OTC Drug Price Forecast by Type (2021-2026)
5 Global OTC Drug Market Size by Application
5.1 Global OTC Drug Historic Market Review by Application (2015-2020)
5.1.1 Global OTC Drug Sales Market Share by Application (2015-2020)
5.1.2 Global OTC Drug Revenue Market Share by Application (2015-2020)
5.1.3 Global OTC Drug Price by Application (2015-2020)
5.2 Global OTC Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global OTC Drug Sales Forecast by Application (2021-2026)
5.2.2 Global OTC Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global OTC Drug Price Forecast by Application (2021-2026)
6 United States OTC Drug Market Facts & Figures
6.1 United States OTC Drug Sales Market Share by Company (2015-2020)
6.2 United States OTC Drug Sales Market Share by Type (2015-2020)
6.3 United States OTC Drug Sales Market Share by Application (2015-2020)
7 Europe OTC Drug Market Facts & Figures
7.1 Europe OTC Drug Sales Market Share by Company (2015-2020)
7.2 Europe OTC Drug Sales Market Share by Type (2015-2020)
7.3 Europe OTC Drug Sales Market Share by Application (2015-2020)
8 China OTC Drug Market Facts & Figures
8.1 China OTC Drug Sales Market Share by Company (2015-2020)
8.2 China OTC Drug Sales Market Share by Type (2015-2020)
8.3 China OTC Drug Sales Market Share by Application (2015-2020)
9 Japan OTC Drug Market Facts & Figures
9.1 Japan OTC Drug Sales Market Share by Company (3015-3030)
9.2 Japan OTC Drug Sales Market Share by Type (2015-2020)
9.3 Japan OTC Drug Sales Market Share by Application (2015-2020)
10 Southeast Asia OTC Drug Market Facts & Figures
10.1 Southeast Asia OTC Drug Sales Market Share by Company (2015-2020)
10.2 Southeast Asia OTC Drug Sales Market Share by Type (2015-2020)
10.3 Southeast Asia OTC Drug Sales Market Share by Application (2015-2020)
11 India OTC Drug Market Facts & Figures
11.1 India OTC Drug Sales Market Share by Company (2015-2020)
11.2 India OTC Drug Sales Market Share by Type (2015-2020)
11.3 India OTC Drug Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in OTC Drug Business
12.1 Bayer HealthCare
12.1.1 Bayer HealthCare Corporation Information
12.1.2 Bayer HealthCare Business Overview
12.1.3 Bayer HealthCare OTC Drug Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Bayer HealthCare OTC Drug Products Offered
12.1.5 Bayer HealthCare Recent Development
12.2 GlaxoSmithKline (GSK)
12.2.1 GlaxoSmithKline (GSK) Corporation Information
12.2.2 GlaxoSmithKline (GSK) Business Overview
12.2.3 GlaxoSmithKline (GSK) OTC Drug Sales, Revenue and Gross Margin (2015-2020)
12.2.4 GlaxoSmithKline (GSK) OTC Drug Products Offered
12.2.5 GlaxoSmithKline (GSK) Recent Development
12.3 Johnson&Johnson
12.3.1 Johnson&Johnson Corporation Information
12.3.2 Johnson&Johnson Business Overview
12.3.3 Johnson&Johnson OTC Drug Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Johnson&Johnson OTC Drug Products Offered
12.3.5 Johnson&Johnson Recent Development
12.4 Pfizer
12.4.1 Pfizer Corporation Information
12.4.2 Pfizer Business Overview
12.4.3 Pfizer OTC Drug Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Pfizer OTC Drug Products Offered
12.4.5 Pfizer Recent Development
12.5 Sanofi
12.5.1 Sanofi Corporation Information
12.5.2 Sanofi Business Overview
12.5.3 Sanofi OTC Drug Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Sanofi OTC Drug Products Offered
12.5.5 Sanofi Recent Development
12.6 AstraZeneca
12.6.1 AstraZeneca Corporation Information
12.6.2 AstraZeneca Business Overview
12.6.3 AstraZeneca OTC Drug Sales, Revenue and Gross Margin (2015-2020)
12.6.4 AstraZeneca OTC Drug Products Offered
12.6.5 AstraZeneca Recent Development
12.7 BioGaia
12.7.1 BioGaia Corporation Information
12.7.2 BioGaia Business Overview
12.7.3 BioGaia OTC Drug Sales, Revenue and Gross Margin (2015-2020)
12.7.4 BioGaia OTC Drug Products Offered
12.7.5 BioGaia Recent Development
12.8 Bristol Myers Squibb
12.8.1 Bristol Myers Squibb Corporation Information
12.8.2 Bristol Myers Squibb Business Overview
12.8.3 Bristol Myers Squibb OTC Drug Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Bristol Myers Squibb OTC Drug Products Offered
12.8.5 Bristol Myers Squibb Recent Development
12.9 Bukwang Pharmaceutica
12.9.1 Bukwang Pharmaceutica Corporation Information
12.9.2 Bukwang Pharmaceutica Business Overview
12.9.3 Bukwang Pharmaceutica OTC Drug Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Bukwang Pharmaceutica OTC Drug Products Offered
12.9.5 Bukwang Pharmaceutica Recent Development
12.10 Chr. Hansen
12.10.1 Chr. Hansen Corporation Information
12.10.2 Chr. Hansen Business Overview
12.10.3 Chr. Hansen OTC Drug Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Chr. Hansen OTC Drug Products Offered
12.10.5 Chr. Hansen Recent Development
12.11 Cipla
12.11.1 Cipla Corporation Information
12.11.2 Cipla Business Overview
12.11.3 Cipla OTC Drug Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Cipla OTC Drug Products Offered
12.11.5 Cipla Recent Development
12.12 CoLucid
12.12.1 CoLucid Corporation Information
12.12.2 CoLucid Business Overview
12.12.3 CoLucid OTC Drug Sales, Revenue and Gross Margin (2015-2020)
12.12.4 CoLucid OTC Drug Products Offered
12.12.5 CoLucid Recent Development
12.13 Daiichi Sankyo
12.13.1 Daiichi Sankyo Corporation Information
12.13.2 Daiichi Sankyo Business Overview
12.13.3 Daiichi Sankyo OTC Drug Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Daiichi Sankyo OTC Drug Products Offered
12.13.5 Daiichi Sankyo Recent Development
12.14 Friggs
12.14.1 Friggs Corporation Information
12.14.2 Friggs Business Overview
12.14.3 Friggs OTC Drug Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Friggs OTC Drug Products Offered
12.14.5 Friggs Recent Development
12.15 DSM
12.15.1 DSM Corporation Information
12.15.2 DSM Business Overview
12.15.3 DSM OTC Drug Sales, Revenue and Gross Margin (2015-2020)
12.15.4 DSM OTC Drug Products Offered
12.15.5 DSM Recent Development
12.16 Eisai
12.16.1 Eisai Corporation Information
12.16.2 Eisai Business Overview
12.16.3 Eisai OTC Drug Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Eisai OTC Drug Products Offered
12.16.5 Eisai Recent Development
12.17 Eli Lilly
12.17.1 Eli Lilly Corporation Information
12.17.2 Eli Lilly Business Overview
12.17.3 Eli Lilly OTC Drug Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Eli Lilly OTC Drug Products Offered
12.17.5 Eli Lilly Recent Development
12.18 Herbalife
12.18.1 Herbalife Corporation Information
12.18.2 Herbalife Business Overview
12.18.3 Herbalife OTC Drug Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Herbalife OTC Drug Products Offered
12.18.5 Herbalife Recent Development
12.19 Euradite
12.19.1 Euradite Corporation Information
12.19.2 Euradite Business Overview
12.19.3 Euradite OTC Drug Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Euradite OTC Drug Products Offered
12.19.5 Euradite Recent Development
13 OTC Drug Manufacturing Cost Analysis
13.1 OTC Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of OTC Drug
13.4 OTC Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 OTC Drug Distributors List
14.3 OTC Drug Customers
15 Market Dynamics
15.1 OTC Drug Market Trends
15.2 OTC Drug Opportunities and Drivers
15.3 OTC Drug Market Challenges
15.4 OTC Drug Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global OTC Drug Sales (MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global OTC Drug Sales (MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market OTC Drug Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global OTC Drug Sales (MT) by Region (2015-2020)
Table 5. Global OTC Drug Sales Market Share by Region (2015-2020)
Table 6. Global OTC Drug Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global OTC Drug Revenue Share by Region (2015-2020)
Table 8. Global OTC Drug Sales (MT) Forecast by Region (2021-2026)
Table 9. Global OTC Drug Sales Market Share Forecast by Region (2021-2026)
Table 10. Global OTC Drug Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global OTC Drug Revenue Share Forecast by Region (2021-2026)
Table 12. Global OTC Drug (MT) of Key Companies (2015-2020)
Table 13. Global OTC Drug Sales Share by Company (2015-2020)
Table 14. Global OTC Drug Revenue (US$ Million) by Company (2015-2020)
Table 15. Global OTC Drug Revenue Share by Company (2015-2020)
Table 16. Global OTC Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in OTC Drug as of 2019)
Table 17. Global OTC Drug Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers OTC Drug Manufacturing Sites and Area Served
Table 19. Manufacturers OTC Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key OTC Drug Players
Table 22. Global OTC Drug Sales (MT) by Type (2015-2020)
Table 23. Global OTC Drug Sales Share by Type (2015-2020)
Table 24. Global OTC Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global OTC Drug Price (MT) by Type (2015-2020)
Table 26. Global OTC Drug Sales Share by Type (2021-2026)
Table 27. Global OTC Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global OTC Drug Revenue Share by Type (2021-2026)
Table 29. Global OTC Drug Price (MT) by Type (2021-2026)
Table 30. Global OTC Drug Sales (MT) by Application (2015-2020)
Table 31. Global OTC Drug Sales Share by Application (2015-2020)
Table 32. Global OTC Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global OTC Drug Price (MT) by Application (2015-2020)
Table 34. Global OTC Drug Sales (MT) by Application (2021-2026)
Table 35. Global OTC Drug Sales Share by Application (2021-2026)
Table 36. Global OTC Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global OTC Drug Revenue Share by Application (2021-2026)
Table 38. Global OTC Drug Price (MT) by Application (2021-2026)
Table 39. United States OTC Drug Sales (MT) by Company (2015-2020)
Table 40. United States OTC Drug Sales Market Share by Company (2015-2020)
Table 41. United States OTC Drug Sales (MT) by Type (2015-2020)
Table 42. United States OTC Drug Sales Market Share by Type (2015-2020)
Table 43. United States OTC Drug Sales (MT) by Application (2015-2020)
Table 44. United States OTC Drug Sales Market Share by Application (2015-2020)
Table 45. Europe OTC Drug Sales (MT) by Company (2015-2020)
Table 46. Europe OTC Drug Sales Market Share by Company (2015-2020)
Table 47. Europe OTC Drug Sales (MT) by Type (2015-2020)
Table 48. Europe OTC Drug Sales Market Share by Type (2015-2020)
Table 49. Europe OTC Drug Sales (MT) by Application (2015-2020)
Table 50. Europe OTC Drug Sales Market Share by Type (2015-2020)
Table 51. China OTC Drug Sales (MT) by Company (2015-2020)
Table 52. China OTC Drug Sales Market Share by Company (2015-2020)
Table 53. China OTC Drug Sales (MT) by Type (2015-2020)
Table 54. China OTC Drug Sales Market Share by Type (2015-2020)
Table 55. China OTC Drug Sales (MT) by Application (2015-2020)
Table 56. China OTC Drug Sales Market Share by Application (2015-2020)
Table 57. Japan OTC Drug Sales (MT) by Company (2015-2020)
Table 58. Japan OTC Drug Sales Market Share by Company (2015-2020)
Table 59. Japan OTC Drug Sales (MT) by Type (2015-2020)
Table 60. Japan OTC Drug Sales Market Share by Type (2015-2020)
Table 61. Japan OTC Drug Sales (MT) by Application (2015-2020)
Table 62. Japan OTC Drug Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia OTC Drug Sales (MT) by Company (2015-2020)
Table 64. Southeast Asia OTC Drug Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia OTC Drug Sales (MT) by Type (2015-2020)
Table 66. Southeast Asia OTC Drug Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia OTC Drug Sales (MT) by Type (2015-2020)
Table 68. Southeast Asia OTC Drug Sales Market Share by Application (2015-2020)
Table 69. India OTC Drug Sales (MT) by Company (2015-2020)
Table 70. India OTC Drug Sales Market Share by Company (2015-2020)
Table 71. India OTC Drug Sales (MT) by Type (2015-2020)
Table 72. India OTC Drug Sales Market Share by Type (2015-2020)
Table 73. India OTC Drug Sales (MT) by Application (2015-2020)
Table 74. India OTC Drug Sales Market Share by Application (2015-2020)
Table 75. Bayer HealthCare Corporation Information
Table 76. Bayer HealthCare Description and Business Overview
Table 77. Bayer HealthCare OTC Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Bayer HealthCare OTC Drug Product
Table 79. Bayer HealthCare Recent Development
Table 80. GlaxoSmithKline (GSK) Corporation Information
Table 81. GlaxoSmithKline (GSK) Description and Business Overview
Table 82. GlaxoSmithKline (GSK) OTC Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. GlaxoSmithKline (GSK) OTC Drug Product
Table 84. GlaxoSmithKline (GSK) Recent Development
Table 85. Johnson&Johnson Corporation Information
Table 86. Johnson&Johnson Description and Business Overview
Table 87. Johnson&Johnson OTC Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Johnson&Johnson OTC Drug Product
Table 89. Johnson&Johnson Recent Development
Table 90. Pfizer Corporation Information
Table 91. Pfizer Description and Business Overview
Table 92. Pfizer OTC Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Pfizer OTC Drug Product
Table 94. Pfizer Recent Development
Table 95. Sanofi Corporation Information
Table 96. Sanofi Description and Business Overview
Table 97. Sanofi OTC Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Sanofi OTC Drug Product
Table 99. Sanofi Recent Development
Table 100. AstraZeneca Corporation Information
Table 101. AstraZeneca Description and Business Overview
Table 102. AstraZeneca OTC Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. AstraZeneca OTC Drug Product
Table 104. AstraZeneca Recent Development
Table 105. BioGaia Corporation Information
Table 106. BioGaia Description and Business Overview
Table 107. BioGaia OTC Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. BioGaia OTC Drug Product
Table 109. BioGaia Recent Development
Table 110. Bristol Myers Squibb Corporation Information
Table 111. Bristol Myers Squibb OTC Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Bristol Myers Squibb Description and Business Overview
Table 113. Bristol Myers Squibb OTC Drug Product
Table 114. Bristol Myers Squibb Recent Development
Table 115. Bukwang Pharmaceutica Corporation Information
Table 116. Bukwang Pharmaceutica OTC Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Bukwang Pharmaceutica Description and Business Overview
Table 118. Bukwang Pharmaceutica OTC Drug Product
Table 119. Bukwang Pharmaceutica Recent Development
Table 120. Chr. Hansen Corporation Information
Table 121. Chr. Hansen Description and Business Overview
Table 122. Chr. Hansen OTC Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Chr. Hansen OTC Drug Product
Table 124. Chr. Hansen Recent Development
Table 125. Cipla Corporation Information
Table 126. Cipla Description and Business Overview
Table 127. Cipla OTC Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Cipla OTC Drug Product
Table 129. Cipla Recent Development
Table 130. CoLucid Corporation Information
Table 131. CoLucid Description and Business Overview
Table 132. CoLucid OTC Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. CoLucid OTC Drug Product
Table 134. CoLucid Recent Development
Table 135. Daiichi Sankyo Corporation Information
Table 136. Daiichi Sankyo Description and Business Overview
Table 137. Daiichi Sankyo OTC Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 138. Daiichi Sankyo OTC Drug Product
Table 139. Daiichi Sankyo Recent Development
Table 140. Friggs Corporation Information
Table 141. Friggs Description and Business Overview
Table 142. Friggs OTC Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 143. Friggs OTC Drug Product
Table 144. Friggs Recent Development
Table 145. DSM Corporation Information
Table 146. DSM Description and Business Overview
Table 147. DSM OTC Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 148. DSM OTC Drug Product
Table 149. DSM Recent Development
Table 150. Eisai Corporation Information
Table 151. Eisai Description and Business Overview
Table 152. Eisai OTC Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 153. Eisai OTC Drug Product
Table 154. Eisai Recent Development
Table 155. Eli Lilly Corporation Information
Table 156. Eli Lilly Description and Business Overview
Table 157. Eli Lilly OTC Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 158. Eli Lilly OTC Drug Product
Table 159. Eli Lilly Recent Development
Table 160. Herbalife Corporation Information
Table 161. Herbalife Description and Business Overview
Table 162. Herbalife OTC Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 163. Herbalife OTC Drug Product
Table 164. Herbalife Recent Development
Table 165. Euradite Corporation Information
Table 166. Euradite Description and Business Overview
Table 167. Euradite OTC Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 168. Euradite OTC Drug Product
Table 169. Euradite Recent Development
Table 170. Production Base and Market Concentration Rate of Raw Material
Table 171. Key Suppliers of Raw Materials
Table 172. OTC Drug Distributors List
Table 173. OTC Drug Customers List
Table 174. OTC Drug Market Key Trends
Table 175. OTC Drug Key Opportunities and Drivers
Table 176. OTC Drug Market Challenges
Table 177. Research Programs/Design for This Report
Table 178. Key Data Information from Secondary Sources
Table 179. Key Data Information from Primary Sources
List of Figures
Figure 1. OTC Drug Product Picture
Figure 2. Global OTC Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global OTC Drug Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Clinic Examples
Figure 8. Household Examples
Figure 9. Global OTC Drug Sales (MT) Growth Rate (2015-2026)
Figure 10. Global OTC Drug Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global OTC Drug Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 12. Global OTC Drug Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global OTC Drug Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States OTC Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States OTC Drug Sales (MT) Growth Rate (2015-2026)
Figure 16. Europe OTC Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe OTC Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China OTC Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China OTC Drug Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan OTC Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan OTC Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia OTC Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia OTC Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India OTC Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India OTC Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest OTC Drug Players Market Share by Revenue in OTC Drug 2015 & 2019
Figure 27. OTC Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global OTC Drug Revenue Share by Type (2015-2020)
Figure 29. Global OTC Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global OTC Drug Revenue Share by Application (2015-2020)
Figure 31. Global OTC Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States OTC Drug Sales Market Share by Type in 2019
Figure 33. United States OTC Drug Sales Market Share by Type in 2019
Figure 34. Europe OTC Drug Sales Market Share by Company in 2019
Figure 35. Europe OTC Drug Sales Market Share by Type in 2019
Figure 36. Europe OTC Drug Sales Market Share by Application in 2019
Figure 37. China OTC Drug Sales Market Share by Company in 2019
Figure 38. China OTC Drug Sales Market Share by Type in 2019
Figure 39. China OTC Drug Sales Market Share by Application in 2019
Figure 40. Japan OTC Drug Sales Market Share by Company in 2019
Figure 41. Japan OTC Drug Sales Market Share by Type in 2019
Figure 42. Japan OTC Drug Sales Market Share by Application in 2019
Figure 43. Southeast Asia OTC Drug Sales Market Share by Company in 2019
Figure 44. Southeast Asia OTC Drug Sales Market Share by Type in 2019
Figure 45. Southeast Asia OTC Drug Sales Market Share by Application in 2019
Figure 46. India OTC Drug Sales Market Share by Company in 2019
Figure 47. India OTC Drug Sales Market Share by Type in 2019
Figure 48. India OTC Drug Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of OTC Drug
Figure 51. Manufacturing Process Analysis of OTC Drug
Figure 52. OTC Drug Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
I型高脂血症治療薬の世界市場レポート2020 Market Analysis and Insights: Global Type I Hyperlipoproteinemia Drug Market The global Type I Hyperlipoproteinemia Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Type I Hyperlipoproteinemia Drug Scope and Market …- 内分泌系薬の世界市場レポート2020 Market Analysis and Insights: Global Endocrine System Drug Market The global Endocrine System Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Endocrine System Drug Scope and Market Size The global Endocrine System …
- 消化器系治療薬の世界市場レポート2020 Market Analysis and Insights: Global Digestive System Drug Market The global Digestive System Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Digestive System Drug Scope and Market Size The global Digestive System …
- 耳鳴症治療薬の世界市場レポート2020 Market Analysis and Insights: Global Tinnitus Drug Market The global Tinnitus Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Tinnitus Drug Scope and Market Size The global Tinnitus Drug market is segmented by comp…
- 甲状腺ホルモン薬の世界市場レポート2020 Market Analysis and Insights: Global Thyroid Hormone Disorder Drug Market The global Thyroid Hormone Disorder Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Thyroid Hormone Disorder Drug Scope and Market Size The …